In Vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography

Overview

Journal Magn Reson Med Sci

Specialty Radiology

Date 2017 Sep 5

PMID 28867760

Authors

Satoshi Doishita

Taro Shimono

Tetsuya Yoneda

Eiji Yamada

Taro Tsukamoto

Daichi Takemori

Daisuke Kimura

Hiroyuki Tatekawa

Shinichi Sakamoto

Yukio Miki

Affiliations

Soon will be listed here.

Abstract

Purpose: Implantation of carmustine wafers (Gliadel) in vivo is accompanied by characteristic serial changes on MRI and CT, such as transient hyperintensity of the wafers on T-weighted images (TWIs) and considerable gas accumulation in surgical resection cavities. The purpose of this study was to evaluate intrinsic imaging changes to carmustine wafers in vitro.

Methods: Three phantoms simulating a surgical resection cavity were constructed. Each contained either a carmustine wafer fixed with oxidized regenerated cellulose and fibrin sealant, an unfixed carmustine wafer, or a fixed polyethylene control disk, immersed in phosphate-buffered saline. Image acquisition of the phantoms was performed on MRI and CT until 182 days after construction. The radiological appearances of the object in each phantom were assessed by visual evaluation and quantification of the region of interest. The volume of gas around the objects at 24 h after constructing the phantoms was also measured.

Results: The carmustine wafers showed low signal intensities on TWIs and T-weighted images (TWIs), and high densities on CT images at 24 h. The signal intensities and CT densities gradually approximated those of saline over a period of months. However, the carmustine wafers never showed hyperintensity on TWIs in vitro. The fixed carmustine wafer showed slower radiological changes, as compared to the unfixed wafer. The gas volume around the fixed carmustine wafer was greater than that around the fixed control disk.

Conclusion: Changes to the carmustine wafers probably reflected penetration of fluid inside and degradation of the hydrophobic matrix. Reported transient hyperintensity of wafers on TWIs in vivo is regarded as the result of biological reactions, whereas the initial production of gas is considered as an intrinsic characteristic of wafers.

References

Dang W, Daviau T, Brem H . Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy. Pharm Res. 1996; 13(5):683-91. DOI: 10.1023/a:1016035229961. View

Ulmer S, Spalek K, Nabavi A, Schultka S, Mehdorn H, Kesari S . Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma. Neuro Oncol. 2012; 14(4):482-90. PMC: 3309854. DOI: 10.1093/neuonc/nos003. View

In den Kleef J, Cuppen J . RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med. 1987; 5(6):513-24. DOI: 10.1002/mrm.1910050602. View

Masuda Y, Ishikawa E, Yamamoto T, Matsuda M, Akutsu H, Kohzuki H . Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma. Magn Reson Med Sci. 2016; 15(3):299-307. PMC: 5608126. DOI: 10.2463/mrms.mp.2015-0054. View

Della Puppa A, Rossetto M, Ciccarino P, Del Moro G, Rotilio A, Manara R . The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series. Acta Neurochir (Wien). 2010; 152(11):1923-31. DOI: 10.1007/s00701-010-0759-6. View

Prager J, Grenier Y, Cozzens J, CHIOWANICH P, Gorey M, Meyer J . Serial CT and MR imaging of carmustine wafers. AJNR Am J Neuroradiol. 2000; 21(1):119-23. PMC: 7976347. View

Dyke J, Sanelli P, Voss H, Serventi J, Stieg P, Schwartz T . Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla. J Neurooncol. 2006; 82(1):103-10. DOI: 10.1007/s11060-006-9254-6. View

Fung L, Ewend M, Sills A, Sipos E, Thompson R, Watts M . Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 1998; 58(4):672-84. View

Hammoud D, Belden C, Ho A, Dal Pan G, Herskovits E, Hilt D . The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging. AJR Am J Roentgenol. 2003; 180(5):1469-75. DOI: 10.2214/ajr.180.5.1801469. View

10.

Leong K, Brott B, Langer R . Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res. 1985; 19(8):941-55. DOI: 10.1002/jbm.820190806. View

11.

Colen R, Zinn P, Hazany S, Do-Dai D, Wu J, Yao K . Magnetic resonance imaging appearance and changes on intracavitary Gliadel wafer placement: A pilot study. World J Radiol. 2011; 3(11):266-72. PMC: 3226960. DOI: 10.4329/wjr.v3.i11.266. View

12.

Mangraviti A, Tyler B, Brem H . Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapy. Surg Neurol Int. 2015; 6(Suppl 1):S78-84. PMC: 4338488. DOI: 10.4103/2152-7806.151345. View

13.

McGirt M, Than K, Weingart J, Chaichana K, Attenello F, Olivi A . Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg. 2008; 110(3):583-8. PMC: 4856017. DOI: 10.3171/2008.5.17557. View

14.

Lawson H, Sampath P, Bohan E, Park M, Hussain N, Olivi A . Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol. 2006; 83(1):61-70. PMC: 4086528. DOI: 10.1007/s11060-006-9303-1. View

15.

Brem H, Ewend M, Piantadosi S, Greenhoot J, Burger P, Sisti M . The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J Neurooncol. 1995; 26(2):111-23. DOI: 10.1007/BF01060217. View

16.

Landis J, Koch G . The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-74. View

17.

Bjorenson J, Grove H, List Sr M, Haasch G, Austin B . Effects of hemostatic agents on the pH of body fluids. J Endod. 1986; 12(7):289-92. DOI: 10.1016/s0099-2399(86)80110-8. View

18.

Ohue S, Kohno S, Inoue A, Yamashita D, Suehiro S, Seno T . Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence. J Neurooncol. 2015; 126(1):119-126. DOI: 10.1007/s11060-015-1941-8. View

19.

Aoki T, Yamada S . [II. Current status of BCNU stent in the brain for treatment of glioma]. Gan To Kagaku Ryoho. 2013; 40(6):708-17. View

20.

Brem H, MAHALEY Jr M, Vick N, Black K, Schold Jr S, Burger P . Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg. 1991; 74(3):441-6. DOI: 10.3171/jns.1991.74.3.0441. View